Skip to main content
user-generated· regulatory

UK NHS approves oral Wegovy for obesity treatment by 2027-03-31

The NHS is likely to approve the oral Wegovy pill for obesity treatment within 9 months, following clinical review and cost-effectiveness analysis. This would significantly expand patient access beyond private prescriptions.

regulatory · Prediction Market

Implied probability (Yes)
60%
Closes
2027-03-31

More regulatory markets

Browse all regulatory markets →

Loading…